NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-55 Cr | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-7.48 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-2.80 Cr |
| Mar2021 | ₹-12 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-7.48 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-2.80 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹200.1 Cr | -6.3% | -18.6% | -55.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -6.3% |
-18.6% |
-55.6% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses